Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chester A Mathis

Showing results (21-30 of 203) with videos related to

Pageof 21
Sort By:
Journal of Neurochemistry|May 10, 2022
Beyond monoamines: I. Novel targets and radiotracers for Positron emission tomography imaging in psychiatric disordersBrian J Lopresti, Sarah K Royse, Chester A Mathis, et al.
Neuroscience Letters|August 24, 2007
Grooved pegboard test as a biomarker of nigrostriatal denervation in Parkinson's diseaseNicolaas I Bohnen, Hiroto Kuwabara, Gregory M Constantine, et al.
Brain : a Journal of Neurology|October 31, 2006
Two-year follow-up of amyloid deposition in patients with Alzheimer's diseaseWilliam E Klunk, Chester A Mathis, Julie C Price, et al.
Annals of Neurology|June 18, 2016
[F-18]AV-1451 positron emission tomography retention in choroid plexus: More than "off-target" bindingMilos D Ikonomovic, Eric E Abrahamson, Julie C Price, et al.
Biological Psychiatry|January 13, 2018
Amphetamine-Induced Striatal Dopamine Release Measured With an Agonist Radiotracer in SchizophreniaW Gordon Frankle, Jennifer Paris, Michael Himes, et al.
Journal of Medicinal Chemistry|June 13, 2003
Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agentsChester A Mathis, Yanming Wang, Daniel P Holt, et al.
Journal of Molecular Neuroscience : MN|September 6, 2002
Synthesis and evaluation of 2-(3'-iodo-4'-aminophenyl)-6-hydroxybenzothiazole for in vivo quantitation of amyloid deposits in Alzheimer's diseaseYanming Wang, William E Klunk, Guo-Feng Huang, et al.
Bioorganic & Medicinal Chemistry Letters|February 16, 2013
Design, synthesis and structure-activity relationship of rhenium 2-arylbenzothiazoles as β-amyloid plaque binding agentsJinhe Pan, Neale S Mason, Manik L Debnath, et al.
ACS Chemical Neuroscience|March 10, 2025
Radiosynthesis, <i>In Vitro</i> Characterization, and <i>In Vivo</i> PET Neuroimaging of [<sup>18</sup>F]F-4 for Tau Protein: A First-in-Human PET StudyAnton Lindberg, Junchao Tong, Chao Zheng, et al.
Advances in Pharmacology (San Diego, Calif.)|July 31, 2012
Using Pittsburgh Compound B for in vivo PET imaging of fibrillar amyloid-betaAnn D Cohen, Gil D Rabinovici, Chester A Mathis, et al.
Pageof 21

Showing results (21-30 of 203) with videos related to

Sort By:
Pageof 21
Journal of Neurochemistry|May 10, 2022
Beyond monoamines: I. Novel targets and radiotracers for Positron emission tomography imaging in psychiatric disordersBrian J Lopresti, Sarah K Royse, Chester A Mathis, et al.
Neuroscience Letters|August 24, 2007
Grooved pegboard test as a biomarker of nigrostriatal denervation in Parkinson's diseaseNicolaas I Bohnen, Hiroto Kuwabara, Gregory M Constantine, et al.
Brain : a Journal of Neurology|October 31, 2006
Two-year follow-up of amyloid deposition in patients with Alzheimer's diseaseWilliam E Klunk, Chester A Mathis, Julie C Price, et al.
Annals of Neurology|June 18, 2016
[F-18]AV-1451 positron emission tomography retention in choroid plexus: More than "off-target" bindingMilos D Ikonomovic, Eric E Abrahamson, Julie C Price, et al.
Biological Psychiatry|January 13, 2018
Amphetamine-Induced Striatal Dopamine Release Measured With an Agonist Radiotracer in SchizophreniaW Gordon Frankle, Jennifer Paris, Michael Himes, et al.
Journal of Medicinal Chemistry|June 13, 2003
Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agentsChester A Mathis, Yanming Wang, Daniel P Holt, et al.
Journal of Molecular Neuroscience : MN|September 6, 2002
Synthesis and evaluation of 2-(3'-iodo-4'-aminophenyl)-6-hydroxybenzothiazole for in vivo quantitation of amyloid deposits in Alzheimer's diseaseYanming Wang, William E Klunk, Guo-Feng Huang, et al.
Bioorganic & Medicinal Chemistry Letters|February 16, 2013
Design, synthesis and structure-activity relationship of rhenium 2-arylbenzothiazoles as β-amyloid plaque binding agentsJinhe Pan, Neale S Mason, Manik L Debnath, et al.
ACS Chemical Neuroscience|March 10, 2025
Radiosynthesis, <i>In Vitro</i> Characterization, and <i>In Vivo</i> PET Neuroimaging of [<sup>18</sup>F]F-4 for Tau Protein: A First-in-Human PET StudyAnton Lindberg, Junchao Tong, Chao Zheng, et al.
Advances in Pharmacology (San Diego, Calif.)|July 31, 2012
Using Pittsburgh Compound B for in vivo PET imaging of fibrillar amyloid-betaAnn D Cohen, Gil D Rabinovici, Chester A Mathis, et al.
Pageof 21